GeneDx Financial Statements From 2010 to 2024

Stocks . USA . 
Stock . GeneDx Holdings Corp
WGS Stock   57.79  0.40  0.69%   
GeneDx Holdings financial statements provide useful quarterly and yearly information to potential GeneDx Holdings Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on GeneDx Holdings financial statements helps investors assess GeneDx Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting GeneDx Holdings' valuation are summarized below:
Gross Profit
-26.8 M
Profit Margin
(0.48)
Market Capitalization
1.6 B
Enterprise Value Revenue
6.4743
Revenue
243.7 M
There are over one hundred nineteen available fundamental trends for GeneDx Holdings Corp, which can be analyzed over time and compared to other ratios. All traders should confirm GeneDx Holdings' regular fundamentals against the performance from 2010 to 2024 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 91.3 M in 2024, whereas Market Cap is likely to drop slightly above 63.5 M in 2024.

GeneDx Holdings Total Revenue

225.49 Million

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Net Interest Income of 1.2 M, Interest Income of 3.1 M or Depreciation And Amortization of 31.4 M, as well as many indicators such as Price To Sales Ratio of 0.31, Dividend Yield of 0.0 or PTB Ratio of 0.52. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.
  
Check out the analysis of GeneDx Holdings Correlation against competitors.

GeneDx Holdings Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Current Liabilities51 M44.4 M20.7 M
Slightly volatile
Total Current Liabilities92 M58.8 M58.1 M
Slightly volatile
Other Liabilities45.5 M24 M27.6 M
Slightly volatile
Accounts Payable9.7 M10.2 M20.8 M
Pretty Stable
Other Assets0.951.05.2 M
Very volatile
Net Receivables34.5 M32.8 M25.7 M
Slightly volatile
Common Stock Shares Outstanding25.5 M24.3 M9.1 M
Slightly volatile
Inventory15.5 M8.8 M17.1 M
Pretty Stable
Other Current Assets5.7 M10.6 M2.6 M
Slightly volatile
Deferred Long Term Liabilities1.6 M3.1 M973.8 K
Slightly volatile
Total Current Assets267.6 M182.3 M197.2 M
Slightly volatile
Property Plant Equipment67.5 M96.9 M48.5 M
Slightly volatile
Total Assets486.8 M473.7 M318.2 M
Slightly volatile
Short and Long Term Debt Total74.3 M119.8 M53 M
Slightly volatile
Property Plant And Equipment Net74.1 M59.4 M65 M
Slightly volatile
Current Deferred Revenue34.2 K36 K1.3 M
Slightly volatile
Cash146.5 M99.7 M130.7 M
Slightly volatile
Non Current Assets Total197.4 M291.3 M112.7 M
Slightly volatile
Long Term Debt55.3 M52.7 M22.3 M
Slightly volatile
Cash And Short Term Investments152.6 M130.1 M133.1 M
Slightly volatile
Liabilities And Stockholders Equity486.8 M473.7 M318.2 M
Slightly volatile
Non Current Liabilities Total170.5 M186.8 M407.1 M
Slightly volatile
Capital Lease Obligations49.2 M66.6 M31.4 M
Slightly volatile
Total Liabilities246.1 M245.7 M486.2 M
Slightly volatile
Property Plant And Equipment Gross109.4 M105.8 M96 M
Slightly volatile
Short and Long Term Debt472.1 K497 K2 M
Pretty Stable
Non Current Liabilities Other13.9 M25.3 M6.5 M
Slightly volatile
Net Working Capital135 M123.5 M121.1 M
Slightly volatile
Short Term Debt3.8 M4.1 M5 M
Slightly volatile
Common Stock1.9 K2 K22 K
Slightly volatile
Common Stock Total Equity30.4 K34.2 K37.2 K
Slightly volatile
Long Term Debt Total5 M5.6 M6.1 M
Slightly volatile
Capital Surpluse1.1 B1.2 B1.4 B
Slightly volatile
Intangible Assets143.7 M172.6 M182.9 M
Slightly volatile
Accumulated Other Comprehensive Income340 K382.5 K416.5 K
Slightly volatile

GeneDx Holdings Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.1 M2.9 M1.3 M
Slightly volatile
Depreciation And Amortization31.4 M35.8 M15.5 M
Slightly volatile
Interest Expense2.6 M3.7 M1.5 M
Slightly volatile
Selling General Administrative148.1 M133.8 M72.5 M
Slightly volatile
Selling And Marketing Expenses90.5 M61 M57.1 M
Slightly volatile
Total Revenue225.5 M202.6 M201.1 M
Slightly volatile
Other Operating Expenses520.2 M366.2 M328.3 M
Slightly volatile
Research Development77.1 M51.6 M49.5 M
Slightly volatile
Cost Of Revenue202.6 M141.9 M142.9 M
Slightly volatile
Total Operating Expenses317.6 M224.3 M185.3 M
Slightly volatile
Reconciled Depreciation29.3 M33.7 M14.7 M
Slightly volatile
Non Recurring168.1 M189.1 M205.9 M
Slightly volatile
Non Operating Income Net Other58.3 M65.5 M71.4 M
Slightly volatile

GeneDx Holdings Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow170.3 M137.4 M63.7 M
Slightly volatile
Other Cashflows From Financing Activities113 M85.9 M131.6 M
Slightly volatile
Depreciation29.7 M35.8 M14.8 M
Slightly volatile
Capital Expenditures5.4 M5.7 M15.5 M
Pretty Stable
Total Cash From Financing Activities254 M186.2 M182.7 M
Slightly volatile
End Period Cash Flow139.7 M99.7 M136.5 M
Slightly volatile
Change To Netincome78.9 M154 M37.8 M
Slightly volatile
Change To Liabilities19 M17.2 M16.1 M
Slightly volatile
Sale Purchase Of Stock160.5 M180.5 M196.6 M
Slightly volatile
Change Receivables4.4 M5 M5.4 M
Slightly volatile
Cash Flows Other Operating10.6 M11.9 M13 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.310.33018.2187
Slightly volatile
Days Sales Outstanding47.6159.130662.918
Slightly volatile
Capex To Depreciation0.150.15941.8902
Slightly volatile
Inventory Turnover9.8316.17238.6147
Slightly volatile
Days Of Inventory On Hand40.4322.569547.1455
Slightly volatile
Payables Turnover14.5613.86447.423
Slightly volatile
Sales General And Administrative To Revenue0.510.66030.3381
Slightly volatile
Research And Ddevelopement To Revenue0.270.25450.2382
Slightly volatile
Capex To Revenue0.02680.02820.0787
Pretty Stable
Cash Per Share5.095.3532510 K
Slightly volatile
Days Payables Outstanding25.0126.326453.2844
Slightly volatile
Income Quality0.541.02490.6409
Pretty Stable
Intangibles To Total Assets0.410.36440.3811
Pretty Stable
Current Ratio3.223.10012.5764
Slightly volatile
Receivables Turnover6.916.17285.8329
Slightly volatile
Graham Number37.1139.05926.4 M
Slightly volatile
Capex Per Share0.220.234913.7 K
Pretty Stable
Revenue Per Share7.928.331976.9 K
Pretty Stable
Interest Debt Per Share2.222.3376224 K
Slightly volatile
Debt To Assets0.140.120.1623
Slightly volatile
Operating Cycle10681.7001111
Slightly volatile
Days Of Payables Outstanding25.0126.326453.2844
Slightly volatile
Ebt Per Ebit0.721.07960.934
Slightly volatile
Quick Ratio2.972.95082.2722
Slightly volatile
Net Income Per E B T1.090.99481.025
Slightly volatile
Cash Ratio2.21.69471.6603
Slightly volatile
Cash Conversion Cycle46.0655.373755.6477
Slightly volatile
Days Of Inventory Outstanding40.4322.569547.1455
Slightly volatile
Days Of Sales Outstanding47.6159.130662.918
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.41.03171.6121
Slightly volatile
Fixed Asset Turnover2.493.41142.8883
Pretty Stable
Debt Ratio0.140.120.1623
Slightly volatile
Price Sales Ratio0.310.33018.2187
Slightly volatile
Asset Turnover0.550.42760.6452
Slightly volatile

GeneDx Holdings Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap63.5 M66.9 M1.6 B
Slightly volatile

GeneDx Fundamental Market Drivers

Cash And Short Term Investments130.1 M

GeneDx Upcoming Events

20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue36 K34.2 K
Total Revenue202.6 M225.5 M
Cost Of Revenue141.9 M202.6 M
Sales General And Administrative To Revenue 0.66  0.51 
Research And Ddevelopement To Revenue 0.25  0.27 
Capex To Revenue 0.03  0.03 
Revenue Per Share 8.33  7.92 
Ebit Per Revenue(0.81)(0.85)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY